Citius Pharmaceuticals, Inc. — All Filings
617 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-KT
10-Q
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-26-025459 | Mar 10, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-023439 | Mar 4, 2026 | — |
| ARS | FORM ARS | 0001213900-26-019569 | Feb 24, 2026 | Sep 30, 2025 |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-019568 | Feb 24, 2026 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-26-019566 | Feb 24, 2026 | Apr 6, 2026 |
| SCHEDULE 13G/A | — | 0001649553-26-000024 | Feb 17, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-015895 | Feb 13, 2026 | Feb 9, 2026 |
| 10-Q | QUARTERLY REPORT | 0001213900-26-015878 | Feb 13, 2026 | Dec 31, 2025 |
| 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-26-008861 | Jan 28, 2026 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-125413 | Dec 23, 2025 | — |
| 10-K | ANNUAL REPORT | 0001213900-25-125333 | Dec 23, 2025 | Sep 30, 2025 |
| SCHEDULE 13D/A | — | 0001213900-25-122793 | Dec 17, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-116760 | Dec 1, 2025 | — |
| SCHEDULE 13G | — | 0001649553-25-000174 | Oct 27, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-101741 | Oct 23, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-100847 | Oct 21, 2025 | Oct 20, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-100559 | Oct 21, 2025 | — |
| 4 | — | 0001213900-25-090602 | Sep 23, 2025 | Aug 8, 2025 |
| SCHEDULE 13D/A | — | 0001213900-25-087227 | Sep 12, 2025 | — |
| 4 | — | 0001213900-25-075035 | Aug 12, 2025 | Aug 8, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-075034 | Aug 12, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-074997 | Aug 12, 2025 | Jun 30, 2025 |
| SCHEDULE 13D/A | — | 0001213900-25-067797 | Jul 25, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-062099 | Jul 8, 2025 | Jul 7, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-053607 | Jun 12, 2025 | Jun 9, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-053274 | Jun 11, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-052718 | Jun 9, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-050822 | Jun 3, 2025 | Jun 2, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-049550 | May 30, 2025 | May 29, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-043360 | May 14, 2025 | Mar 31, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-043362 | May 14, 2025 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-035757 | Apr 28, 2025 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-035755 | Apr 28, 2025 | Jun 9, 2025 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-25-033368 | Apr 18, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-033366 | Apr 18, 2025 | Apr 16, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-028622 | Apr 3, 2025 | Mar 28, 2025 |
| 8-K | CURENT REPORT | 0001213900-25-028003 | Apr 2, 2025 | Apr 1, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-027540 | Apr 2, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-022237 | Mar 10, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-014359 | Feb 14, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-014321 | Feb 14, 2025 | Dec 31, 2024 |
| 8-K | CURRENT REPORT | 0001213900-25-010747 | Feb 6, 2025 | — |
| 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-25-006997 | Jan 27, 2025 | Sep 30, 2024 |
| ARS | FORM ARS | 0001213900-25-006993 | Jan 27, 2025 | Sep 30, 2024 |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-25-006987 | Jan 27, 2025 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-006984 | Jan 27, 2025 | Mar 10, 2025 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-25-004221 | Jan 16, 2025 | Jan 10, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-002071 | Jan 8, 2025 | Jan 7, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-001826 | Jan 8, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-001408 | Jan 7, 2025 | — |